SEMAGLUTIDE and tirzepatide have emerged as promising treatments for weight management in adults without diabetes. These glucagon-like peptide-1 (GLP-1) receptor agonists have demonstrated significant ...

While there is not currently a shortage of Ozempic, previous difficulties in supplying this medication have led to some pharmacies offering compounded semaglutide. The Food and Drug Administration ...

"With the FDA announcing the resolution of shortages for Semaglutide (Wegovy, Ozempic) and Tirzepatide (Zepbound, Mounjaro), compounding pharmacies must halt production of these medications. This ...

Intel has also promoted networking chip chief Sachin Katti to be chief technology officer and artificial intelligence chief, according to the memo. The leadership changes are the first major move ...

Five GLP-1RAs are available in the UK-dulaglutide, exenatide, liraglutide, lixisenatide, and semaglutide, which is the active ingredient in Ozempic and Wegovy. Article continues below Ozempic is ...

Another Eli Lilly-sponsored study compared Mounjaro (tirzepatide) and Trulicity (dulaglutide), two of its GLP-1 drugs for diabetes, in a head-to-head trial. After 40 weeks, Mounjaro resulted in ...

An earthquake in central Myanmar just unearthed an ancient structure that may be part of a royal “water palace,” experts say. Previously, only a staircase was visible. Now, after the ...

Several other formulations with unique structures and properties are being investigated in ongoing clinical trials including albiglutide, semaglutide, dulaglutide and ITCA650. Published and ...

SAN FRANCISCO, April 17 (Reuters) - Intel's (INTC.O), opens new tab new CEO, Lip-Bu Tan, is flattening the semiconductor giant's leadership team, with important chip groups reporting directly to ...

Introduction: Semaglutide (2.4 mg) and liraglutide (3.0 mg) are glucagon-like peptide-1 receptor agonist (GLP-1 RA) drugs used to promote weight loss, with evidence indicating a greater effect for ...

He added the HbA1c reduction and weight loss reported in the top-line results are similar to what has been observed with once-weekly dulaglutide (Trulicity, Eli Lilly), though they not nearly as ...